IMPCL registers threefold increase in its profits of Rs 45.41 crore for FY 21-22
Company pays a dividend of Rs 9.93 crore to the Ministry of AYUSH
The Indian Medicines Pharmaceutical Corporation (IMPCL), a Central Public Sector Enterprise (CPSE), under the Ministry of AYUSH, has announced to pay a dividend of Rs 10.13 crore to its stakeholders – Ministry of AYUSH and Government of Uttarakhand. The dividend cheque of Rs 9.93 crore for the Ministry of AYUSH was handed over to Sarbananda Sonowal, Union Minister of AYUSH, in a ceremony held at Transport Bhawan recently.
Speaking in this regard, Sonowal said, “IMPCL Ltd has registered an impressive increase in its profits in comparison to the last FY20-21, which is commendable achievement. Under the visionary leadership of Hon’ble Prime Minister Shri Narendra Modi, AYUSH sector is witnessing all-round growth not only in India, but globally.”
IMPCL has been conferred Mini Ratna Category II status by the Government of India. The company is currently manufacturing 656 classical Ayurvedic, 332 Unani and 71 proprietary Ayurvedic medicines for the various diseases spectrum. It supplies Ayurveda and Unani medicines to all the states under the National AYUSH Mission (NAM) and 6,000 centres of Jan Aushadhi Kendras (JAKs).
Dr Mukesh Kumar, MD, IMPCL, said, “In the operational front, the company has achieved an enhancement of 47 per cent in capacity utilisation over its previous year. An all-around enhancement in performance in terms of turnover, profit and capacity utilisation over previous years has brought focus on the future prospects of the company.”